Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates

被引:85
作者
Brandel, JP [1 ]
Delasnerie-Lauprêtre, N
Laplanche, JL
Hauw, JJ
Alpérovitch, A
机构
[1] Hop La Pitie Salpetriere, INSERM, U360, F-75651 Paris 13, France
[2] Hop Lariboisiere, Serv Biochim & Biol Mol, F-75475 Paris, France
[3] Hop La Pitie Salpetriere, Lab Neuropathol R Escourolle, F-75651 Paris, France
[4] Hop La Pitie Salpetriere, Reseau Francais Neuropathol, F-75651 Paris, France
关键词
Creutzfeldt-Jakob disease; clinical criteria;
D O I
10.1212/WNL.54.5.1095
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the effect of usage of three different versions of Creutzfeldt-Jakob disease (CJD) diagnostic criteria on estimates of CJD incidence, Methods: A total of 428 patients referred for suspected sporadic CJD between 1991 and 1997 were classified according to different criteria to be compared after analysis of medical records. Specificity, sensitivity, and positive and negative predictive values were calculated for each set of criteria in the subgroup of patients with a postmortem examination. Positive and negative predictive values of the clinical diagnosis were applied to cases without postmortem examination. Subsequently, the true number of cases of CJD among the referred cases was estimated. Results: By comparison with the French and European study criteria, the Masters' criteria showed higher sensitivity but lower specificity and positive predictive value. Comparison with an estimate of the true total number of CJD cases showed that Masters' criteria overestimated the incidence by 7%, whereas the French and the European study criteria led to an underestimate of 12%. Detection of the 14-3-3 protein in CSF, considered as an additional diagnostic criterion for clinically probable CJD, resulted in a slight increase in the estimated incidence when the French or European study criteria were applied. Conclusions: Different diagnostic criteria could lead to an under- or overestimation of the true incidence of CJD. Therefore, comparisons of CJD incidence in different countries should rely on diagnostic classifications using identical criteria, Taking into account 14-3-3 protein detection as a criterion for probable CJD will result in a small increase in the estimated CJD incidence.
引用
收藏
页码:1095 / 1099
页数:5
相关论文
共 7 条
[1]   14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease [J].
Beaudry, P ;
Cohen, P ;
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Richard, S ;
Launay, JM ;
Laplanche, JL .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) :40-46
[2]  
CATHALA F, 1979, REV NEUROL, V5, P439
[3]   CREUTZFELDT-JAKOB DISEASE - PATTERNS OF WORLDWIDE OCCURRENCE AND THE SIGNIFICANCE OF FAMILIAL AND SPORADIC CLUSTERING [J].
MASTERS, CL ;
HARRIS, JO ;
GAJDUSEK, DC ;
GIBBS, CJ ;
BERNOULLI, C ;
ASHER, DM .
ANNALS OF NEUROLOGY, 1979, 5 (02) :177-188
[4]   A new variant of Creutzfeldt-Jakob disease in the UK [J].
Will, RG ;
Ironside, JW ;
Zeidler, M ;
Cousens, SN ;
Estibeiro, K ;
Alperovitch, A ;
Poser, S ;
Pocchiari, M ;
Hofman, A ;
Smith, PG .
LANCET, 1996, 347 (9006) :921-925
[5]   Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease [J].
Zerr, I ;
Bodemer, M ;
Gefeller, O ;
Otto, M ;
Poser, S ;
Wiltfang, J ;
Windl, O ;
Kretzschmar, HA ;
Weber, T .
ANNALS OF NEUROLOGY, 1998, 43 (01) :32-40
[6]  
1994, 2 M ROM JUL 3 1993 3
[7]  
1998, M AMST JUN 12 13